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ABSTRACT
In this paper, phycocyanin and one component (PY-D2) in
polysaccharide were obtained from Porphyra yezoensis to
study for their potential anti-tumor effects. MTT proliferation
assays showed that, at concentration of 500 mg/L for 72 h,
PY-D2 treatment significantly inhibited the growth of four
tumor cell lines, HO-8910, MCF-7, K562 and SMMC-7721,
with the respective inhibition rates of 21.2%, 23.6%, 19.8%,
and 21%. Flow cytometry analysis indicated that the anti-tumor effect of PY-D2 was associated with the cell cycle arrest at
G0/G1 or G2/M check-points. Two cancer cell lines, Hep-2
and A375 were treated by different concentrations of phycocyanin, followed by radiation with He-Ne laser at the density
of 20 J/cm2 and the wavelength of 632 nm. MTT assays displayed the minimal survival rate of 29.8% (Hep-2) and 16.2%
(A375) at 100 μg/ml and 165 μg/ml respectively. These results suggest that both polysaccharide and phycocyanin from
Porphyra yezoensis might be useful in the treatment of human
cancers. These results suggest that phycocyanin and one
component (PY-D2) in polysaccharide which had been obtained both from Porphyra yezoensis were potential medicaments in the treatment of some kinds of human cancers.

I. INTRODUCTION
Polysaccharide and phycobiliprotein were two important
bioactive substances of Porphyra yezoensis, an algal species
well known for its nutritional value and widely used as a
healthy food in Asia [13, 18]. Polysaccharide has attracted
great attentions for its benefits to human health, such as reducing blood pressure [31], anti-fatigue effect, improving the
Paper submitted 06/09/09; revised 11/24/09; accepted 03/31/10. Author for
correspondence: Pei-Min He (e-mail: pmhe@shou.edu.cn).
*Key Laboratory of Aquatic Genetic Resources and Aquacultural Ecosystem,
The Ministry of Agriculture, Shanghai Ocean University, Shanghai, P.R. China.

function of immune system [10, 38] and protecting against
hepatotoxicity induced by carbon tetrachloride [9]. On the
other hand, phycocyanin, a phycobiliprotein of the alga, has
also been widely used as a food additive and cosmetic colorant
[5]. Phycocyanin extracted from Spirulina platensis displayed
favorable health benefits such as improving immune function,
promoting zooblast regeneration and inhibiting the growth of
cancer cells [30]. Since phycocyanin is photosensitive, it has
been proposed as a new photosensitizer for photodynamic
therapy [3, 22, 23, 27].
Previous studies have already suggested that both polysaccharides and phycobiliproteins from certain algal species
may inhibit the growth of tumor cells [3, 16, 22-24, 27]. To
further confirm such findings and to explore the health benefits of Porphyra yezoensis, we studied effects of polysaccharide and phycocyanin on the growth of human tumor cell
lines.

II. MATERIALS AND METHODS
1. Polysaccharide and Phycocyanin
Polysaccharide was purified and two single components
PY-D1 and PY-D2 were obtained following the previous
protocol [8, 9]. Flesh blades of Porphyra yezoensis were dried
and cut into small pieces. Lipids were removed by alcohol
circumfluence and polysaccharides were extracted with hot
water for 3 h. The extract added with mixture of chloroform
and butanol were vibrated at 350 rpm for a while, followed by
15 min centrifugalism at 4000 rpm [20]. The precipitation removed and the polysaccharides in suspension were precipitated by 95% alcohol before being further purified by DEAE-52
column and Sephadex G-200 column. In DEAE-52 chromatography, PY-D1 and PY-D2 were eluted with distilled water
and 3 N NaCl at 0.5 ml/min [21].
The procedures of isolation and purification of phycocyanin were described previously [2]. Briefly, total proteins were
extracted from thallus of Porphyra yezoensis through the
combination of dissolving-bulging and tissue-homogenator
methods. After the precipitation by 20% ammonium sulphate,
phycocyanin in the upper solution was further precipitated by
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50% ammonium sulphate. After another two rounds of similar
precipitation with 10% and 40% ammonium sulphate, the phycocyanin precipitation was resuspended into 50 mM phosphate buffer (pH 6.8), and further desalted and purified by
hydroxylapatite column. The purity of final phycocyanin
preparation was determined by spectrophotometry.
2. Culture Media and Chemicals
The cell culture media RPMI 1640, DMEM, and fetal bovine serum (FBS) were purchased from Gibco. MTT and SDS
was purchased from Sigma. DEAE-52 and Sephadex G-200
were purchased from GE. Other chemicals (ammonium sulphate, alcohol, sodium chloride, chloroform, calcium chloride
anhydrous, disodium hydrogen phosphate dodecahydrate,
sodium dihydrogen phosphate dehydrate) were of analytical
grade from commercial sources.
3. Tumor Cell Lines
Human ovarian cancer cell line HO-8910, human breast
cancer cell line MCF-7, human leukemia cell line K562 and
human hepatocellular carcinoma cell line SMMC-7721 were
kindly provided by Second Military Medical University.
Human laryngeal carcinoma cell line Hep-2 and human malignant melanoma cell line A375 were purchased from Chinese Academy of Sciences.
4. MTT Proliferation Assays for Cells after PY-D2
Treatment
HO-8910, MCF-7, K562, and SMMC-7721 cells were cultured in RPMI1640 media containing 10% FBS. 100 μl of
cells was plated into each well of a 96-well plate at the density
of 5 × 105/ml. Then the cells were incubated at 37°C with
5% CO2. 10 μl of PY-D2 dissolved in 0.9% of NaCl solution
was added into each well 24 h later, to the final concentrations
of 5 mg/L, 25 mg/L, 50 mg/L, 100 mg/L, 500 mg/L and 1000
mg/L to HO-8910 and MCF-7 cells, as well as 25 mg/L, 50
mg/L, 100 mg/L, 500 mg/L to K562 and SMMC-7721 cells.
0.9% of NaCl solution alone was used as the control for the
experiment. Each concentration group for each cell line had
12 replicates. After 72 h, 10 μl of 5 g/L MTT was added into
each well and cells were incubated for another 4-6 h at 37°C.
Then 10% SDS was added and the OD values at 595 nm was
measured with a microplate reader (λ = 595 nm) in the following day. The cell growth inhibition rate was calculated
according to the following formula: Inhibition rate = (( A control –
A PY-D2 ) / A control ) × 100%.

5. Flow Cytometry Analysis
Flow cytometry analysis was performed similarly as described previously [40]. Two groups of cells were analyzed the 0.9% NaCl solution control group and the 500 mg/L
PY-D2 treatment group. The cultured cells in the logarithmic
phase were centrifuged, the cell pellets were resuspended in
70% ethanol, and fixed at -20°C overnight. Then the cells

were washed twice with PBS, and incubated with 1 mg/ml
RNaseA and 50 μg/ml proteinase inhibitor at room temperature in dark for 30 min. Treated cells were then stained for
their nuclear contents by Propidium Iodide (PI), and analyzed
by flow cytometry for the cell cycle progression.
6. MTT Proliferation Assays for Cells after Phycocyanin
Treatment

Hep-2 and A375 cells were first cultured in RPMI1640
media containing 10% FBS. Then the cultured cells in the
logarithmic phase were centrifuged, the cell pellets were resuspended in RPMI1640. 50 μl of the above cells were plated
into each well of a 96-well plate at the density of 106/ml. Then
the cells were incubated at 37°C with 5% CO2. The concentrations of phycocyanin in the four groups of Hep-2 cells were
set to 5 μg/ml, 25 μg/ml, 50 μg/ml and 100 μg/ml, respectively;
and those in the five A375 groups were 10 μg/ml, 25 μg/ml, 50
μg/ml, 100 μg/ml and 165 μg/ml, respectively. Each concentration group for each cell line included 6 replicates. After 4 h
of incubation with phycocyanin, the treated cells were irradiated with He-Ne laser at a density of 20 J/cm2 and a wavelength of 632 nm. Then 50 μl of RPMI 1640 containing 20%
FBS was added into each well. After 72 h, 10 μl of 5 g/L MTT
was added into each well and incubated for another 4-6 h at
37°C. Then 10% SDS was added and the OD values were
obtained by microplate reader (λ = 595 nm) in the following
day. The none-treatment group was set as the normal control
and the laser irradiated group without phycocyanin treatment
was set as the negative control. The cell survival rate of cells
after radiation was calculated according to the formula: Survival rate = (A phycocyanin/laser / A normal control ) × 100%. In case for
the calculation of survival rate of negative control, A phycocyanin/laser
was replaced with A laser .
7. Statistical Analysis
All the data were expressed as mean ± SD and subjected to
a one-way analysis of variance (ANOVA) followed by a t-test
for multiple comparisons. For a single comparison, the significance of differences between the means was determined by
the Student’s t-test. p < 0.05 was considered as statistically
significant.

III. RESULTS
1. Purification of Polysaccharide and Phycocyanin
Extracted from Porphyra yezoensis
Fig. 1 was the chromatogram of the polysaccharide elution
from DEAE-52 column. The two distinct and sharp absorption peaks indicated a good separation of two components by
the column. The purified polysaccharide, named PY-D1 and
PY-D2, were mainly non-anion and anion polysaccharides,
which became white flocculus after lyophilization.
C-phycocyanin crude extracted from Porphyra yezoensis
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Fig. 1. Chromatogram of polysaccharide extracted from Porphyra yezoensis. PY-D1 was unabsorbed and eluted by distilled water,
while PY-D2 was absorbed by DEAE-52 column and eluted by 3
N NaCl at 0.5 ml/min.
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Fig. 2. Absorption of C-phycocyanin from Porphyra yezoensis after hydroxylapatite chromatography.

was purified by hydroxylapatite chromatography. The chromatogram in Fig. 2 shows that the absorption peak at 615 nm
for phycocyanin exceeded 4.5 fold of the absorption peak at
280 nm, indicating a good purity of phycocyanin. The yield of
phycocyanin was determined to be 0.07% of dry weight by
spectrophotometry.
2. Inhibitory Effect of Polysaccharide on the Growth of
Four Cancer Cell Lines
The effects of polysaccharide PY-D2 on the growth of
HO-8910, MCF-7, K562 and SMMC-7721 cells were investigated. Fig. 3 shows that PY-D2 significantly inhibited the
growth of all tumor cell lines dose-dependently. The inhibiting effect of PY-D2 on MCF-7 was stronger than on the other
three tumor cell lines under the same concentrations. MCF-7
cell growth was inhibited by 23.6% and 32.5% (p < 0.001),
respectively, under concentrations of 500 and 1000 mg/L
PY-D2 (Fig. 3(a)); HO-8910 cell growth rate was inhibited
23.9% (p < 0.001) by PY-D2 at concentration of 1000 mg/L
(Fig. 3(b)); the growth rates of K562 and SMMC-7721 cells
were inhibited by 19.8% (Fig. 3(c)) and 21% (p < 0.001),
respectively (Fig. 3(d)), under 500 mg/L PY-D2.
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3. Flow Cytometry Analysis of Tumor Cell Lines Treated
with Polysaccharide
Flow cytometry analysis showed rangement in the percentages of cells under different cell cycle stages after PY-D2
treatment. For SMMC-7721 cell line, the percentage of G0/G1
stage cells increased while that of G2/M stage cells decreased;
there was no significant change in the percentage of S stage
cells (Fig. 4(a)). For the HO-8910 cell line, the percentage of
G0/G1 stage cells increased while that of S stage cells decreased; no significant change in the percentage of G2/M stage
cells was observed (Fig. 4(b)). For the MCF-7 cell line and
K562 cell line, the percentage of G0/G1 stage cells decreased
while that of the G2/M stage cells increased; no significant
change in the percentage of S stage cells was observed (Fig.
4(c), 4(d)).
4. Inhibitory Effect of Phycocyanin on the Growth of
Cancer Cells
Phycocyanin treatment at concentrations higher than 5
μg/ml caused dose-dependent inhibition of the growth of
Hep-2 cells (p < 0.01, Fig. 5). The survival rates of Hep-2
cells reduced to 83.1%, 53.8% and 29.8%, respectively, correspond to the baseline survival rate of the non-treatment
group (all p values < 0.01), under the three increasing concentrations of phycocyanin. The laser treatment alone also
showed some inhibitory effect on the growth of Hep-2 cells,
with the cell survival rate reduced to 89.2% (p < 0.05).
In the experiments with A375 cells, all five dosage levels of
phycocyanin significantly inhibited the growth of A375 cells
(all p values < 0.01). With the increase of phycocyanin concentration, the survival rates of A375 were reduced to 81.3%,
68.0%, 17.2%, 16.2% and 11.8% respectively (all p values <
0.01), showing a dose-dependent effect (Fig. 6). In the experiments with A375 cells, the cell survival rate of the laser
treatment group without PY-D2 treatment was 86.4% (p <
0.05), which was similar to the laser group of Hep-2 cells.

IV. DISCUSSION
Polysaccharides from Porphyra yezoensis have been reported to accelerate the proliferation of mouse spleen lymphocytes, marrow cells and macrophages [10, 34, 38]. Our
data showed that they also inhibited the growth of a panel of
human tumor cell lines, and such effects were dose-dependent.
Cell cycle is very important to the regulation of tumor
growth. There are two checkpoints of the cell cycle: the G1
and the G2 checkpoints. The G1 checkpoint decides whether
the cells enter S stage via G1 stage, and it is the driving force
of the cell cycle. The G2 checkpoint is the monitoring
mechanism of the cell cycle [35]; it ensures the high accuracy
of DNA duplication and prevents cells with damaged or unduplicated DNAs from entering mitosis (M) stage [11, 26].
More and more scholars are attaching importance to the
studies of inhibiting human tumor growth through the regulation of cell cycle of tumor cells [6]. In this study, the flow
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Fig. 3. (a) Inhibiting effect of PY-D2 on proliferation of MCF-7 cells after 72 h treatment. #p < 0.05, ##p < 0.01, ###p < 0.001 as compared with control
(0), n = 12, X ± S, (b) Inhibiting effect of PY-D2 on proliferation of HO-8910 cells after 72 h treatment. #p <0.05, ##p < 0.01, ###p < 0.001 as
compared with control (0), n = 12, X ± S, (c) Inhibiting effect of PY-D2 on proliferation of K562 cells after 72 h treatment. #p < 0.05, ##p < 0.01,
###
p < 0.001 as compared with control (0), n = 12, X ± S, (d) Inhibiting effect of PY-D2 on proliferation of SMMC-7721 cells after 72 h treatment.
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Fig. 4. (a) Effect of PY-D2 on the cell cycle of SMMC-7721 (n = 6, X ± S), (b) Effect of PY-D2 on the cell cycle of HO-8910 (n = 6, X ± S), (c) Effect of
PY-D2 on the cell cycle of MCF-7 (n = 6, X ± S), (d) Effect of PY-D2 on the cell cycle of K562 (n = 6, X ± S).
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Fig. 6. Effect of phycocyanin (PC) from Porphyra yezoensis on A375 (n =
6, X ± S) (**p < 0.01)

cytometry analyses showed that the polysaccharide from Porphyra yezoensis causes cancer cell cycle arrested at the G0/G1
or the G2/M check points.
Although our understanding on the mechanism underlying
the anti-cancer effects of polysaccharide from Porphyra yezoensis is still far from complete, previous studies have shown
that the algal polysaccharides may directly and/or indirectly
inhibit the growth of tumor cells. The algal polysaccharides
can prolong the cell cycle of the tumor cells or cause the tumor
cells to undergo apoptosis by regulating signaling molecules
such as NF-κB, Smad3 [19]. The change of Ca2+ concentration [15] or the down-regulation of bcl-2 expression [32] induced by the algal polysaccharides can also lead the tumor
cells to apoptosis. In addition, the algal polysaccharides can
indirectly inhibit the growth of tumor cells by improving the
immune functions or inhibiting DNA synthesis [39].
Besides, we have done some experiments about the effect
of polysaccharide on other cells in our lab before. We have
found the polysaccharide could advance the growth of mouse
spleen lymphocytes, the result of flow cytometry indicated
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that polysaccharide from Porphyra yezoensis could promote
mouse spleen lymphocytes to enter into S phase from G1
phase [37]. We also found that the polysaccharide from Porphyra yezoensis can obviously promote the growth of the rat
sertoli cells [38]. So the inhibitory effect of polysaccharide
from Porphyra yezoensis is not a general cytotoxicity of the
chemicals on any cells, it is specific to the cancer cells.
Photodynamic therapies (PDT) for treating malignant tumors have been developed rapidly in recent years [1]. The
photosensitizers can absorb luminous energy and convert oxygen to singlet oxygen (1O2), a powerful reactive oxygen species (ROS) that can kill tumor cells [14]. As a photosensitizer
of potential important values in PDT, phycocyanin extracted
from algae has attracted much attention [7]. Previous studies
have reported that phycocyanin from Spirulina platensis inhibited the growth of human hepatocellular carcinoma cell line
SMMC-7721 [4], human rectal cancer cell line HR8348 [12],
and human leukemia HL-60, as well as K562 and U937 cell
line [36]. Phycocyanin from Porphyra haitanensis was also
reported to inhibit the growth of HL-60 cells [22]. Since phycocyanin from Porphyra yezoensis has not been investigated
for such effects yet, our study presented the first report on the
dose-dependent inhibitory effects of Porphyra yezoensis on
the growth of various human tumor cells (Figs. 5 and 6). Our
data also suggest phycocyanin from Porphyra yezoensis as a
candidate for anti-cancer therapeutics in addition to the phycocyanins isolated form other algae.
The mechanism underlying the anti-tumor effects of phycocyanin may be related to the interference of DNA synthesis
in tumor cells [25, 33] or the ability of phycocyanin to improve
the immune functions [28, 29]. The most recent report showed
that phycocyanin bound to the mitogen receptor on the tumor
cell membrane and sitmulated the surface expression of CD59,
thereby activating the cellular apoptotic signal transduction
[17].
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